India · English
Sun Pharma board approves plan to raise up to ₹10,000 crore via NCDs
The decision was taken at a meeting of the company's Board of Directors held on October 12, Sun Pharma said in a regulatory filing
Read the full report at Business Standard →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.